IGF-1-induced epithelial–mesenchymal transition in MCF-7 cells is mediated by MUC1 |
| |
Institution: | 1. School of Life Science and Technology, China Pharmaceutical University, Nanjing, China;2. Simcere Pharmaceutical Co., Ltd., Nanjing, Jiangsu, China;3. BioSciKin Co., Ltd., Nanjing, Jiangsu, China;4. MtC BioPharma Co., Ltd., Nanjing, Jiangsu, China |
| |
Abstract: | Metastases are the major cause of death from cancer. IGF-1 signaling pathway has been shown to have strong implication in the epithelial–mesenchymal transition (EMT) process. However, the mechanisms of how IGF-1 promotes EMT have not been fully elucidated. Mucin 1 (MUC1), a transmembrane glycoprotein, engages in multiple cancer-related signaling pathways and functions as an oncoprotein that contributes to metastases. Here we provide evidence showing that IGF-1 upregulates MUC1 expression in MCF-7 cells in a PI3K/Akt signaling pathway-dependent manner. The overexpression of MUC1 is critical for IGF-1-induced EMT of MCF-7 cells because the knockdown of MUC1 prevented the EMT of MCF-7 cells as demonstrated by various EMT markers including the expression of E-cadherin, N-cadherin, vimentin, fibronectin and the nuclear translocalization of β-catenin. On the other hand, the knockdown of MUC1 had no impact on IGF-1-induced activation of PI3K/Akt or MAPK. In summary, our study demonstrated MUC1 as a critical downstream effector that mediates IGF-1-induced EMT of MCF-7 cells and suggested that MUC1 might be a potential therapeutic target for preventing tumor metastases. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|